Filter

DISTRIBUTION OF LIPID VESICLE SIZE AS POTENTIAL MARKER OF NAS SEVERITY: ASSESSMENT WITH MORPHOQUANT-NASH AND MRI

Time-efficient and Reliable Automated Liver Fibrosis Quantification in Preclinical Fibrosis Models using WSI

Automated Digital Quantification of Pulmonary Fibrosis in Human Histopathology Specimens

Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse Model

CSF1R inhibition prevents radiation pulmonary fibrosis by depletion of interstitial macrophages

Radiation-induced lung fibrosis is associated with M2 interstitial and hybrid alveolar macrophages

Engineering DNA vaccines against infectious diseases

Development of pulmonary fibrosis after heart failure induced by elevated left atrial pressure

A fully automated image analysis method to quantify lung fibrosis in the bleomycin- induced rat model

Utilization of a Deep Learning Algorithm for Microscope-Based Fatty Vacuole Quantification in a Fatty Liver Model in Mice

Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects

Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation

Consumption of a high energy density diet triggers microbiota dysbiosis, hepatic lipidosis, and microglia activation in the nucleus of the solitary tract in rats

Existing and emerging treatments for idiopathic pulmonary fibrosis

Oral Administration of Chitosan Attenuates Bleomycin-induced Pulmonary Fibrosis in Rats

Polyporus Polysaccharide Ameliorates Bleomycin-Induced Pulmonary Fibrosis by Suppressing Myofibroblast Differentiation via TGF-b/Smad2/3 Pathway

Deep neural network based histological scoring of lung fibrosis and inflammation in the mouse model system

Longitudinal study of Pex1-G844D NMRI mouse model: A robust pre-clinical T model for mild Zellweger spectrum disorder

Monitoring the Health Status of Mice with Bleomycin-induced Lung Injury by Using Body Condition Scoring

Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis

Bleomycin Revisited: A Direct Comparison of the Intratracheal Micro-Spraying and the Oropharyngeal Aspiration Routes of Bleomycin Administration in Mice

Early microcystin-LR exposure-linked inflammasome activation in mice causes development of fatty liver disease and insulin resistance

Follow-up of NAFLD/NASH progression using an automated histological image analysis

Fully Automated Histology Analysis Correlates with Ashcroft Scoring, MicroCT Analysis and Lung Function Measurement in a Mouse Model of Bleomycin-­induced Lung Fibrosis

Distal lung epithelial progenitor cell function declines with age

Diet Reversal and Immune Modulation Show Key Role for Liver and Adipose Tissue T Cells in Murine Nonalcoholic Steatohepatitis

Automated computerized image analysis for the user-independent evaluation of disease severity in preclinical models of NAFLD/NASH

Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21

Functional and morphological differences of the lung upon acute and chronic ozone exposure in mice.

Quantification of Pulmonary Fibrosis in a Bleomycin Mouse Model Using Automated Histological Image Analysis.